Abstract
OBJECTIVE: We investigated the effect of recombinant human GH (rhGH) on erythropoietin (EPO) and haemoglobin (Hb) concentrations in anaemic patients with adult GH deficiency. PATIENTS AND DESIGN: rhGH was administrated in 8 patients with adult GH deficiency, three males and five females, aged from 24 to 69 years, mean (± SD) of 48.8 ± 16.4 years, for 1 year by means of continuous subcutaneous infusion (CSI) at a flow rate of 0.036 U/kg/day using a portable syringe pump. Blood samples were obtained in the morning after an overnight fast every week for 1 month, followed by each month before and after the start of rhGH administration. RESULTS: Mean (± SE) plasma GH levels increased from 0.24 ± 0.09 μg/l to 2.32 ± 0.23 μg/l 1 week after the start of rhGH administration to maintain a steady state. Plasma IGF-I levels increased from 70.1 ± 13.8 μg/l to 282.8 ± 70.6 mg/l 1 week after the start of rhGH administration to maintain the steady state. Plasma EPO levels increased from 25.9 ± 2.6 IU/l to 37.6 ± 4.2 IU/l and 34.3 ± 3.6 IU/l at 1 week and 2 weeks after the start of rhGH administration, respectively, and then decreased gradually to 14.9 ± 2.1 IU/l at 10 months after the start of rhGH administration. Reticulocyte counts increased from 0.88 ± 0.06% to 1.49 ± 0.21% at 1 week. Hb concentrations increased from 103 ± 5 g/l to 106 ± 5 g/l at 2 weeks after the start of rhGH administration, and then increased gradually to reach the normal range. CONCLUSIONS: We conclude that EPO secretion was stimulated in the initial 2 weeks after the start of CSI of rhGH in anaemic patients with adult GH deficiency. Increased Hb concentrations after long-term administration of rhGH might be explained by direct stimulatory effects of rhGH and IGF-I on erythroid cells, which was accompanied by suppressed EPO secretion, in combination with a more generalized indirect impact of rhGH on physical activety. These findings suggest a beneficial effect of rhGH replacement in anaemic patients with adult GH deficiency.
Cite
CITATION STYLE
Sohmiya, M., & Kato, Y. (2001). Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult gh deficiency. Clinical Endocrinology, 55(6), 749–754. https://doi.org/10.1046/j.1365-2265.2001.01417.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.